Mortally in siblings of patients coinfected with HIV and hepatitis C virus

Journal of Infectious Diseases

Volumn 195, Issue 2, 2007, Pages 230-235

  Hansen, Ann Brit Eg ^a,b   Gerstoft, Jan ^c   Kronborg, Gitte ^d   Pedersen, Court ^a,b   Sørensen, Henrik Toft ^e,f   Obel, Niels ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Rigshospitalet   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SIBLING; SUPERINFECTION; SURVIVAL; VIRUS VIRULENCE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MIDDLE AGED; PATHOGENICITY;

ADULT; COHORT STUDIES; DENMARK; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MORTALITY; SIBLINGS; SURVIVAL ANALYSIS;

EID: 33846148000     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510246     Document Type: Article

References (27)

1. Rockstroh JK, Mocroft A, Soriano V, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. I Infect Dis 2005; 192:992-1002.
2. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-7.
3. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-5.
4. Weis N, Lindhardt BØ, Kronborg G, et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a Danish nationwide cohort study. Clin Infect Dis 2006; 42:1481-7.
5. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002; 288:199-206.
6. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18:2039-45.
7. Tedaldi EM, Baker RK, Moorman AC, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003; 36:363-7.
8. Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 2005; 41:713-20.
9. Nuñez M, Soriano V. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients. J Infect Dis 2005; 191: 1-3.
10. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES, Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005; 191:4-10.
11. Lohse N, Hansen A, Jensen-Fangel S, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005; 37:338-43.
12. The Civil Registration System in Denmark. Available at: http://www.cpr .dk/Index/dokumenter.asp?o=7&n=0&d=141&s=5. Accessed 16 January 2006.
13. Christensen K, Schmidt MM, Vaeth M, Olsen J. Absence of an environmental effect on the recurrence of facial-cleft defects. N Engl J Med 1995; 333:161-4.
14. Smith GD, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study. BMJ 1998; 316:1631-5.
15. Galobardes B, Lynch JW, Davey SG. Childhood socioeconomic circumstances and cause-specific mortality in adulthood: systematic review and interpretation. Epidemiol Rev 2004; 26:7-21.
16. Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA. Adoption study demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry 1995; 52:42-52.
17. Petersen L, Nielsen GG, Andersen PK, Sorensen TI. Case-control study of genetic and environmental influences on premature death of adult adoptees. Genet Epidemiol 2002; 23:123-32.
18. Petersen L, Andersen PK, Sorensen TI. Premature death of adult adoptees: analyses of a case-cohort sample. Genet Epidemiol 2005; 28:376-82.
19. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727-32.
20. Jensen-Fangel S, Pedersen L, Pedersen C, et al. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS 2004; 18:89-97.
21. Frank L. Epidemiology: when an entire country is a cohort. Science 2000; 287:2398-9.
22. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340:1228-33.
23. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46.
24. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000; 32:91-6.
25. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44(1 Suppl):S6-9.
26. Hart CL, Davey SG. Relation between number of siblings and adult mortality and stroke risk: 25 year follow up of men in the Collaborative study. J Epidemiol Community Health 2003; 57:385-91.
27. Ege P. Death among drug addicts. Ugeskr Laeger 2000; 162:5198.